Trials / Completed
CompletedNCT02881892
Iplasma IL6, Procalcitonin and VEGF and Dialysate Level in CAPD Patients
Interleukin-6, Procalcitonin and Vascular Endothelial Growth Factor in Plasma and Dialysate Correlate With Peritoneal Solute Transport and Dialysis Adequacy in CAPD Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 26 (actual)
- Sponsor
- Bangkok Metropolitan Administration Medical College and Vajira Hospital · Other Government
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The aim of study was to evaluated the correlation between plasma levels, dialysate appearance rate of VEGF, inflammatory cytokines (IL- 6, procalcitonin) and PSTR, dialysis adequacy in CAPD patients.
Detailed description
This cross -sectional study measured IL-6, procalcitonin and VEGF level in plasma and overnight effluent. PSTR of small solutes was evaluated by standard peritoneal equilibration test (standard PET). Weekly Kt/V and creatinine clearance (CCr ) were evaluated in all patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Measure plasma and dialysate level of IL-6, procalcitonin and VEGF | correlation between plasma levels, dialysate appearance rate of VEGF, inflammatory cytokines (IL- 6, procalcitonin) and PSTR, dialysis adequacy in CAPD patients. |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2014-05-01
- Completion
- 2014-06-01
- First posted
- 2016-08-29
- Last updated
- 2016-08-29
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT02881892. Inclusion in this directory is not an endorsement.